Overexpression of SCAMP3 is an indicator of poor prognosis in hepatocellular carcinoma

被引:19
|
作者
Zhang, Xinyuan [1 ]
Sheng, Jie [2 ]
Zhang, Yuhong [3 ]
Tian, Yu [4 ]
Zhu, Jie [5 ]
Luo, Nan [1 ]
Xiao, Congshu [1 ]
Li, Rongkuan [1 ]
机构
[1] Dalian Med Univ, Dept Infect, Hosp 2, Dalian, Liaoning, Peoples R China
[2] Dalian Med Univ, Dept Nephrol, Hosp 2, Dalian, Liaoning, Peoples R China
[3] Dalian Med Univ, Dept Ultrasound, Hosp 2, Dalian, Liaoning, Peoples R China
[4] Dalian Med Univ, Div Hepatobiliary & Pancreat Surg, Dept Surg, Hosp 2, Dalian, Liaoning, Peoples R China
[5] Dalian Med Univ, Clin Lab, Hosp 2, Dalian, Liaoning, Peoples R China
关键词
hepatocellular carcinoma; secretory carrier membrane protein 3; prognosis; CARRIER MEMBRANE-PROTEINS; GROWTH-FACTOR RECEPTOR; GENE-EXPRESSION; MOLECULAR-MECHANISMS; CELL-MIGRATION; FACTOR-ALPHA; LIVER; ENDOCYTOSIS; CANCER; REVEALS;
D O I
10.18632/oncotarget.22665
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
SCAMP3, an isoform of the secretory carrier membrane proteins (SCAMPs) family, is a membrane-trafficking protein involved in endosome transport. Previous microarray data showed that SCAMP3 mRNA is highly expressed in hepatocellular carcinoma (HCC). In this study, the expression and clinical significance of SCAMP3 in 100 pairs of HCC and adjacent normal tissue were investigated. siRNA transfection was performed to silence SCAMP3 expression in HCC cells. The MTS assay and flow cytometry were used to detect the proliferation, cell cycle progression of HCC cells. Compared with adjacent normal tissues, SCAMP3 expression was dramatically increased in HCC tissues demonstrated by Western blotting (P < 0.05). In immunohistochemistry, compared with the adjacent normal tissues, SCAMP3 was detected in 96% of the HCC samples with a significant increase in intensity and number of stained cells (P < 0.05). Also, high SCAMP3 expression was found in 86% of the HCC samples (P < 0.05). The increased SCAMP3 expression was significantly correlated with vascular invasion (P = 0.004) and tumor stage (P = 0.001). Univariate and multivariate survival analyses showed that the expression of SCAMP3 was an independent prognostic factor of overall survival of HCC patients. Knockdown of SCAMP3 expression led to suppression of cell proliferation and blockage of cell cycle of HCC cells. In conclusion, our present study suggested that SCAMP3 may serve as a promising prognostic biomarker and molecular target of HCC and further investigation is warranted.
引用
收藏
页码:109247 / 109257
页数:11
相关论文
共 50 条
  • [21] Overexpression of RALY promotes migration and predicts poor prognosis in hepatocellular carcinoma
    Zhu, Zebin
    Zhang, Yixi
    Huang, Chensong
    Tang, Yunhua
    Sun, Chengjun
    Ju, Weiqiang
    He, Xiaoshun
    [J]. CANCER MANAGEMENT AND RESEARCH, 2018, 10 : 5559 - 5572
  • [22] Overexpression of PARPBP Correlates with Tumor Progression and Poor Prognosis in Hepatocellular Carcinoma
    Bin Yu
    Youming Ding
    Xiaofeng Liao
    Changhua Wang
    Bin Wang
    Xiaoyan Chen
    [J]. Digestive Diseases and Sciences, 2019, 64 : 2878 - 2892
  • [23] Overexpression of ARK5 is associated with poor prognosis in hepatocellular carcinoma
    Cui, Jing
    Yu, Yong
    Lu, Gao-Feng
    Liu, Chao
    Liu, Xia
    Xu, Yu-Xian
    Zheng, Peng-Yuan
    [J]. TUMOR BIOLOGY, 2013, 34 (03) : 1913 - 1918
  • [24] Serglycin (SRGN) overexpression predicts poor prognosis in hepatocellular carcinoma patients
    He, Lu
    Zhou, Xinke
    Qu, Chen
    Tang, Yunqiang
    Zhang, Qiong
    Hong, Jian
    [J]. MEDICAL ONCOLOGY, 2013, 30 (04)
  • [25] SKA1 overexpression is associated with poor prognosis in hepatocellular carcinoma
    Chen, Yibing
    Zhao, Jingjing
    Jiao, Zhihui
    Wang, Weiwei
    Wang, Dandan
    Yu, Xiaohe
    Shi, Zhiyong
    Ge, Naijian
    Pan, Qiuzhong
    Xia, Jianchuan
    Niu, Wancheng
    Zhao, Ruihua
    Zhang, Xiaofei
    Du, Wei
    [J]. BMC CANCER, 2018, 18
  • [26] Serglycin (SRGN) overexpression predicts poor prognosis in hepatocellular carcinoma patients
    Lu He
    Xinke Zhou
    Chen Qu
    Yunqiang Tang
    Qiong Zhang
    Jian Hong
    [J]. Medical Oncology, 2013, 30
  • [27] Overexpression of GIHCG is Associated with a Poor Prognosis and Immune Infiltration in Hepatocellular Carcinoma
    Xiao, Siyu
    Huang, Shanzhou
    Yang, Jie
    [J]. ONCOTARGETS AND THERAPY, 2020, 13 : 11607 - 11619
  • [28] Overexpression of SETD8 is associated with poor prognosis in hepatocellular carcinoma
    Suzaki, Norihiko
    Hayami, Shinya
    Ueno, Masaki
    Miyamoto, Atsushi
    Nakamura, Masashi
    Kato, Hirotaka
    Kawai, Manabu
    Okada, Kenichi
    Hirono, Seiko
    Miyazawa, Motoki
    Kitahata, Yuji
    Hamamoto, Ryuji
    Yamaue, Hiroki
    [J]. CANCER SCIENCE, 2021, 112 : 677 - 677
  • [29] CCL15 overexpression predicts poor prognosis for hepatocellular carcinoma
    YueGuo Li
    Hai Peng Yu
    Peng Zhang
    [J]. Hepatology International, 2016, 10 : 488 - 492
  • [30] SKA1 overexpression is associated with poor prognosis in hepatocellular carcinoma
    Yibing Chen
    Jingjing Zhao
    Zhihui Jiao
    Weiwei Wang
    Dandan Wang
    Xiaohe Yu
    Zhiyong Shi
    Naijian Ge
    Qiuzhong Pan
    Jianchuan Xia
    Wancheng Niu
    Ruihua Zhao
    Xiaofei Zhang
    Wei Du
    [J]. BMC Cancer, 18